Guselku vs Ixe...

Ixekizumab May Be More Effective At Improving Signs, Symptoms Of Moderate To Severe Plaque Psoriasis Than Guselkumab, Phase 4 Study Indicates

Healio (1/15, Welsh) reports research indicates that ixekizumab appears "to be more effective at improving signs and symptoms among patients with moderate to severe plaque psoriasis than" guselkumab, investigators concluded in a "multicenter, randomized, double-blind, parallel-group, phase 4 study" that included 1,027 patients. The findings were published online in the British Journal of Dermatology.

        Guselkumab May Be More Effective Than Ustekinumab For Achieving, Maintaining Treatment Responses In Moderate To Severe Plaque Arthritis, Research Suggests. Dermatology Advisor (1/15, May) reports researchers compared individual patient data from clinical trials for guselkumab and ustekinumab and concluded that guselkumab "may be more effective than ustekinumab for helping patients with moderate to severe plaque psoriasis achieve and maintain treatment response through 40 weeks." The findings were published online in the British Journal of Dermatology.

Sent from my iPhone

Benjamin Hidalgo-Matlock
Skin Care Physicians of Costa Rica

Clinica Victoria en San Pedro: 4000-1054
Momentum Escazu: 2101-9574

Please excuse the shortness of this message, as it has been sent from
a mobile device.